drugset / Trial / NCT00476424
A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects
Phase 2
Completed
28 enrolled
The HIV Netherlands Australia Thailand Research Collaboration
Ministry of Education, Thailand · collab
Non-randomizedCrossoverOpen-labelTreatment
Summary
A Pharmacokinetic study of once daily Efavirenz 400 mg versus 600 mg in Thai HIV-1 infected subjects.
Timeline
- Start
- 2007-06
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Efavirenz | Other / unclassified | 400 mg | Oral |
| Comparator | Efavirenz | Other / unclassified | 600 mg | Oral |